Economic burden of skin and skin structure infections due to Gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT)

被引:2
作者
Miron-Rubio, Manuel [1 ,2 ]
Parra Jordan, Juan Jose [3 ]
Gonzalez Ramallo, Victor Jose [4 ]
Mujal Martinez, Abel [5 ]
Fernandez Muixi, Josefina [6 ]
Iglesias Gallego, Marina [7 ]
Lucas Nunez, Maria Cruz [8 ]
Rodado Alabau, Elisa [9 ]
Perez-Campoamor, Sandra Vidal [10 ]
Uria, Estefany [11 ]
机构
[1] Hosp Univ Torrejon, Unidad Hospitalizac, Torrejon De Ardoz, Madrid, Spain
[2] Univ Francisco Vitoria, Fac Med, Madrid, Spain
[3] Hosp Univ Marques Valdecilla, Unidad Hospitalizac & Domicilio, Santander, Santander, Spain
[4] Hosp Gen Univ Gregorio Maranon, Unidad Hospitalizac & Domicilio, Madrid, Madrid, Spain
[5] Hosp Univ Parc Tauli, Unidad Hospitalizac & Domicilio, Sabadell, Barcelona, Spain
[6] Pius Hosp Valls, Unidad Hospitalizac & Domicilio, Serv Med Interna, Valls, Tarragona, Spain
[7] Hosp Barbanza, Unidad Hospitalizac & Domicilio, Ribeira, A Coruna, Spain
[8] Hosp Univ Burgos, Unidad Hospitalizac & Domicilio, Burgos, Burgos, Spain
[9] Verge Cinta, Unidad Hospitalizac Domicilio, Tortosa, Tarragona, Spain
[10] Merck Sharp & Dohme Ltd, Madrid, Spain
[11] Pharmalex Spain, Market Access Area, Barcelona, Spain
关键词
Hospital at home; outpatient parenteral antimicrobial therapy (OPAT); cost analysis; skin and skin structure infections (SSSIs); SOFT-TISSUE INFECTIONS; RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL THERAPY; COMPLICATED SKIN; MANAGEMENT; EXPERIENCE; ADULTS; UK; EPIDEMIOLOGY; ORITAVANCIN;
D O I
10.37201/req/134.2022
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objective. To describe and quantify resource use and direct health costs associated with skin and skin structure infections (SSSIs) caused by Gram-positive bacteria in adults receiving outpatient parenteral antimicrobial therapy (OPAT), administered by Hospital at Home units (HaH) in Spain. Material and methods. Observational, multicenter, retrospective study. We included patients of both sexes included in the HaH-based OPAT Registry during 2011 to 2017 who were hospitalized due to SSSIs caused by Gram-positive bacteria. Resource use included home visits (nurses and physician), emergency room visits, conventional hospitalization stay, HaH stay and antibiotic treatment. Costs were quantified by multiplying the natural units of the resources by the corresponding unit cost. All costs were updated to 2019 euros. Results. We included 194 episodes in 189 patients from 24 Spanish hospitals. The most frequent main diagnoses were cellulitis (26.8%) and surgical wound infection (24.2%), and 94% of episodes resulted in clinical improvement or cure after treatment. The median HaH stay was 13 days (interquartile range [IR]:8-22.7), and the conventional hospitalization stay was 5 days (IR: 1-10.7). The mean total cost attributable to the complete infectious process was _7,326 (95% confidence interval: _6,316-_8,416). Conclusions. Our results suggest that OPAT administered by HaH is a safe and efficient alternative for the management of these infections and could lead to lower costs compared with hospital admission.
引用
收藏
页码:291 / 301
页数:11
相关论文
共 59 条
[1]  
Alonso G, 2010, AN SIST SANIT NAVAR, V33, P97, DOI 10.4321/s1137-66272010000200012
[2]   Optimizing the Clinical Use of Vancomycin [J].
Alvarez, Rocio ;
Lopez Cortes, Luis E. ;
Molina, Jose ;
Cisneros, Jose M. ;
Pachon, Jeronimo .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) :2601-2609
[3]   Effectiveness, safety and cost analysis of dalbavancin in clinical practice [J].
Arrieta-Loitegui, Maria ;
Manuel Caro-Teller, Jose ;
Ortiz-Perez, Sara ;
Lopez-Medrano, Francisco ;
San Juan-Garrido, Rafael ;
Miguel Ferrari-Piquero, Jose .
EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2022, 29 (01) :55-58
[4]   Home intravenous antibiotics in a tertiary care hospital in Saudi Arabia [J].
Baharoon, Salim ;
Almodaimeg, Hind ;
Al Watban, Haifa ;
Al Jahdali, Hamdan ;
Alenazi, Thamer ;
Al Sayyari, Abdullah ;
Al Dawood, Abdulaziz ;
Al-Sultan, Mohammed ;
Al Safi, Eiman .
ANNALS OF SAUDI MEDICINE, 2011, 31 (05) :457-461
[5]   Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years [J].
Barr, D. A. ;
Semple, L. ;
Seaton, R. A. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (05) :407-413
[6]   European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10years of experience with linezolid [J].
Bassetti, M. ;
Baguneid, M. ;
Bouza, E. ;
Dryden, M. ;
Nathwani, D. ;
Wilcox, M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 :3-18
[7]   Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections [J].
Bork, Jacqueline T. ;
Heil, Emily L. ;
Berry, Shanna ;
Lopes, Eurides ;
Dave, Rohini ;
Gilliam, Bruce L. ;
Amoroso, Anthony .
INFECTIOUS DISEASES AND THERAPY, 2019, 8 (02) :171-184
[8]   Dalbavancin in the treatment of different gram-positive infections: a real-life experience [J].
Bouza, Emilio ;
Valerio, Maricela ;
Soriano, Alex ;
Morata, Laura ;
Garcia Carus, Enrique ;
Rodriguez-Gonzalez, Carmen ;
Hidalgo-Tenorio, Ma Carmen ;
Plata, Antonio ;
Munoz, Patricia ;
Vena, Antonio .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (04) :571-577
[9]   Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis [J].
Bryce, Ashley ;
Hay, Alastair D. ;
Lane, Isabel F. ;
Thornton, Hannah V. ;
Wootton, Mandy ;
Costelloe, Ceire .
BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
[10]   Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement [J].
Chapman, Ann L. N. ;
Seaton, R. Andrew ;
Cooper, Mike A. ;
Hedderwick, Sara ;
Goodall, Vicky ;
Reed, Corienne ;
Sanderson, Frances ;
Nathwani, Dilip .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (05) :1053-1062